Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05104515 |
| Title | First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Oxford Vacmedix UK Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University College London Hospitals NHS Foundation Trust | RECRUITING | London | W1T 7HA | United Kingdom | Details | |
| Sarah Cannon Research Institute UK | RECRUITING | London | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | RECRUITING | Manchester | M20 4BX | United Kingdom | Details | |
| Oxford University Hospitals NHS Foundation Trust | NOT_YET_RECRUITING | Oxford | United Kingdom | Details |